MyFinsight
Home
Blog
About
Back
Cash Flow
Greenwich LifeSciences, Inc. (GLSI)
Greenwich LifeSciences, Inc. (GLSI)
source: myfinsight.com
Sale of common stock
via atm program, net...
$310,664
(-89.98%↓ Y/Y)
Net cash provided by
financing activities
$310,664
(-89.98%↓ Y/Y)
Net increase
(decrease) in cash
-$1,629,082
(-68.49%↓ Y/Y)
Canceled cashflow
$310,664
Stock-based compensation
$1,484,762
(-51.92%↓ Y/Y)
Accounts payable
$519,472
(336.75%↑ Y/Y)
Unreimbursed expenses
related party (accrued)
$4,695
(-32.31%↓ Y/Y)
Net cash used in
operating activities
-$1,939,746
(52.31%↑ Y/Y)
Canceled cashflow
$2,008,929
Net loss
-$3,948,675
(45.79%↑ Y/Y)
Back